Guidance

Artwork for medicines containing codeine and dihydrocodeine

This guidance sets out the warning that might be displayed on pack of medicines containing codeine and dihydrocodeine.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 29 December 2014

This publication was withdrawn on 1 January 2021

This page has been withdrawn because the content is no longer up-to-date.

Documents

Guidance on the development of artwork in relation to medicines containing codeine and dihydrocodeine

PDF, 251 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This guidance sets out the requirements for all packaging components for medicines containing codeine and dihydrocodeine, following a change in the indications for over-the-counter products.

Published 29 December 2014